Literature DB >> 20814893

Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?

Thierry Thevenot, Jean-Paul Cervoni, Elisabeth Monnet, Frances Sheppard, Vincent Di Martino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20814893     DOI： 10.1002/hep.23839

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  Improving survival in decompensated cirrhosis.

Authors:  Amar Nath Mukerji; Vishal Patel; Ashokkumar Jain
Journal:  Int J Hepatol       Date:  2012-07-02

2.  Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; Sonia Alonso; Maria-Luisa Gutiérrez; Conrado Fernández-Rodriguez
Journal:  BMJ Open Gastroenterol       Date:  2016-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.